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Abstract
Quantitative real-time PCR assays are widely used for the quantification of mRNA within
avian experimental samples. Multiple stably-expressed reference genes, selected for the
lowest variation in representative samples, can be used to control random technical varia-
tion. Reference gene assays must be reliable, have high amplification specificity and effi-
ciency, and not produce signals from contaminating DNA. Whilst recent research papers
identify specific genes that are stable in particular tissues and experimental treatments,
here we describe a panel of ten avian gene primer and probe sets that can be used to iden-
tify suitable reference genes in many experimental contexts. The panel was tested with Taq-
Man and SYBR Green systems in two experimental scenarios: a tissue collection and virus
infection of cultured fibroblasts. GeNorm and NormFinder algorithms were able to select
appropriate reference gene sets in each case. We show the effects of using the selected
genes on the detection of statistically significant differences in expression. The results are
compared with those obtained using 28s ribosomal RNA, the present most widely accepted
reference gene in chicken work, identifying circumstances where its use might provide mis-
leading results. Methods for eliminating DNA contamination of RNA reduced, but did not
completely remove, detectable DNA. We therefore attached special importance to testing
each qPCR assay for absence of signal using DNA template. The assays and analyses
developed here provide a useful resource for selecting reference genes for investigations of
avian biology.
Introduction
Measurement of mRNA by quantitative RT-PCR (qRT-PCR) is applied in a wide variety of dif-
ferent experimental contexts. Valid interpretation of results depends crucially on the elimina-
tion of irrelevant variation, especially random and systematic variation in recovery of RNA. In
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many experimental designs, it is appropriate to convert raw results into quantities relative to
the measured amounts of other transcripts in the samples, internal reference transcripts, whose
variation under experimental conditions is expected to be minimal. This process is usually
referred to as normalisation. Ample evidence has accumulated showing that commonly used ref-
erence transcripts are not universally effective, because the proportion of transcripts they repre-
sent may be modulated under the experimental conditions being investigated. In these cases,
attempted normalisation leads to systematic bias in the measurement of other transcripts. Conse-
quently, it is necessary to select and validate appropriate reference transcripts whenever they are
applied in a new experimental context. However, in spite of prominent promotion of these
requirements, the avian research field has been slow to adopt these recommendations. Some
recent avian gene expression experiments have identified GAPDH, beta actin and 28s as stable
reference genes during specific viral infections of particular tissues and cells [1–3], and others as
suitable for immune cells subject to mitogen stimulation [4]. Although sets of candidate reference
transcript assays are also offered commercially, their providers have chosen not to reveal full
details of their design, contravening the basic requirement for independent verification. No set of
reference genes is likely to be suitable for every different experimental condition and for this rea-
son that we have developed a panel of candidate genes and reference assays, from which a subset
of stable genes can be chosen for each experimental context.
A variety of algorithms are available for the selection of the most stable reference genes for a
particular set of experimental samples. Two of these which have been widely used are the geN-
orm algorithm [5] and NormFinder [6]. Each starts with a panel of candidate genes, whose
transcripts are expected to be present at constant levels. Measurements of these transcripts in
samples representing the experimental variation are then compared using algorithms to esti-
mate the stability of their levels across the samples. Whilst geNorm uses a single experiment-
wide stability measure, NormFinder uses a method that balances variability within and
between experimental groups. Both are dependent on assumptions about the candidate assays:
geNorm assumes there is no correlation between levels of different candidates, treating inter-
and intra- group variation separately. NormFinder deals with correlated expression by treating
inter and intra-group variation separately, but still depends on the assumption that the average
levels of all the genes are stable. NormFinder can also identify pairs of genes that may be more
stable because of complementing inter-group variation.
Both these methods must start with a set of candidate transcripts for which these assump-
tions have a high likelihood of validity. The aim of this study was to contribute to the develop-
ment of a reliable set of assays for chicken transcripts that would provide a suitable candidate
set for use in many experimental applications.
Materials and Methods
Ethics Statement
All animal procedures were performed in accordance with the UK Animals (Scientific Proce-
dures) Act 1986 [7]. This study was approved by the Pirbright Institute Ethical Review Panel
and the UK Home Office.
Experimental animals
ADOL (Avian Disease and Oncology Laboratory, East Lansing) Line O chickens and Rhode
Island Red chickens (RIR) were obtained from the Pirbright Institute SPF breeding facility,
from parents negative for antibodies to specified pathogens, and were kept in controlled-envi-
ronment isolation rooms with food and water provided ad libitum. Birds were killed using
Schedule 1 methods before harvesting tissues.
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Total RNA extraction from tissues
Samples of each of twelve tissues were collected from six 4 week old birds. These were selected to
include those with primary lymphoid function (thymus, Bursa of Fabricius, spleen, caecal tonsil),
muscular tissue (heart), dominated by epithelial cells (liver, kidney, lung), tissues that interface with
the gut content (duodenum, ileum, colon) and the external environment (skin). Approximately
500 mg of tissue were cut into pieces of no more than 1mm across, collected into 2.5 ml of RNA
Later (Ambion, UK), stored at 4°C overnight and then at -20°C for a maximum of 10 days prior to
processing. RNA was extracted from 100 mg samples, using the Trizol Plus RNA Purification kit
(Life Technologies), according to the manufacturer’s instructions. Homogenisation was performed
using aMixer Mill MM300 (Retsch) and 3 mm stainless steel cone balls (Retsch). An on-column
DNAse digestion step was included (Purelink DNAse, Life Technologies). RNA purity was con-
firmed by measurement of the A260:A280 ratio with a NanoDrop 1000 (Thermo Scientific), with all
samples giving readings between 1.9 and 2.0. Whilst he majority of were diluted to have A260
approximately 1.0, some samples with low RNA yields were used at up to ten-fold lower A260.
Chick Embryo Fibroblasts infected with Highly Pathogenic Avian
Influenza virus
The in vitro infection of avian cells, particularly chick embryo fibroblasts (CEF) has become a
favoured technique for the study of cell-autonomous transcriptional responses, including to
influenza, where viral replication itself can also be conveniently assayed by qRT-PCR. CEF
were prepared from each of 4 Line 0 embryos at 11 days of embryonation, plated at 2.4x106 per
well in 6-well plates in 3 ml bicarbonate buffered 199 medium (Sigma) and allowed to adhere
for 16 hours at 37°C in humidified 5% CO2 after which 1 ml of fresh medium was added, with
or without 4000 units of Interferon α (IFNα) (gift from Peter Staeheli). After further incubation
for 3 hours, medium was replaced with 2 ml fresh medium containing 2.2 x 107 pfu highly
pathogenic H5N1 avian influenza virus (A/Swan/Germany/R65/06) at an MOI of approxi-
mately 10, or control medium without virus, for 6 hours.
Macrophage Cell Line
The chicken macrophage cell line HD11 was used as a source of RNA for assaying the amplifi-
cation efficiency and linear dynamic range of each assay.
Total RNA extraction from cells
After washing cell monolayers with cold PBSa, RNA was extracted, from CEF or the macro-
phage cell line HD11 using the MirVana miRNA extraction kit (Ambion) according to manu-
facturer’s instructions. Concentrations of RNA were adjusted to 500 μg/ml, based on A260
measured by Nanodrop. The RNA integrity numbers (RIN) of all samples were over 9.0, as
determined on a 2100 Bioanalyzer (Agilent Technologies).
DNA extraction
A spleen from an adult RIR chicken was macerated in sterile PBS and passed through a 100 μM
cell strainer (Fisher, UK). Cells were resuspended in Histopaque 1119 (Sigma, UK), overlaid
with Histopaque 1083, Histopaque 1077 and finally PBSa. Following centrifugation at 800 x g
for 45 min, cells at the 1119/1083 interface were collected and washed twice in sterile PBSa.
DNA was prepared from 3x107 cells resuspended in 1.5 ml TNE buffer (10 mM Tris, 1 mM
EDTA, 100 mMNaCl, pH8.0), lysed by addition of 1% SDS, and digested with 0.1 mg/ml pro-
teinase K at 60°C for 16 hours. The solution was extracted with phenol chloroform, then
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chloroform. DNA was precipitated from the aqueous layer with 2.5 volumes of ethanol, spooled
out and washed twice with 75% ethanol before being dissolved in TNE buffer at approximately
100 μg/ml. After treatment with 2 mg/ml RNAse for 1 hour at 37°C and a second proteinase K
digest, DNA was extracted, precipitated and re-dissolved as above. This genomic DNA was
mechanically sheared and purity confirmed, with A260:A280 ratios between 1.7 and 2.0.
Initial reference gene selection and primer design
We identified a set of genes, commonly used as reference genes in diverse species, for which
chicken orthologues were known.
Primer and probe design was undertaken in a two-step process: Candidate primer pairs
were identified using Genscript (https://www.genscript.com/ssl-bin/app/primer) as this gave
the best control over some selection parameters in the initial identification of potential oligonu-
cleotides. In this respect Primer Express (Applied Biosystems, Foster City, California, USA)
was too stringent to offer candidates for all the genes.
However, Primer Express did allow use of a more detailed criteria for the final stages of
design. The melting points calculated by each of the programs were different, and we used the
Primer Express values in the final selection. These primer pairs were experimentally assessed,
by end-point PCR and agarose gel electrophoresis, with both RNA and DNA templates. For
each gene, pairs producing only a single product band of the expected size, from RNA but not
from DNA, were selected for use in qPCR. For 28s ribosomal RNA assays employed in some
analyses, we used a primer-probe set described elsewhere [8].
RT-qPCR
RT-qPCR with TaqMan Probe. Probes incorporated 5-carboxyfluorescein (FAM) at the
50end and N,N,N,N0 tetramethyl-6-carboxyrhodamine (TAMRA) at the 30end. Assays were
carried out using the SuperScript III Platinum One-Step qRT-PCR kit (Invitrogen). Amplifica-
tion and detection of specific products was performed with the 7500 Fast Real Time System
(TaqMan1; Applied Biosystems) with the following cycle profile: 50°C for 5 min, 95°C for 2
min and then 40 cycles of 95°C for 3 sec and 60°C for 30 sec. Generally, 20 ng of RNA was used
for each assay. Standard curves were made starting with larger amounts, so that the experimen-
tal values fell within the range of the standard curves. Dilutions were carried out in 100 μg/ml
carrier RNA (Qiagen) in buffer AVE (Qiagen).
RT-qPCR with SYBR Green. Reverse transcription of 1 μg of total RNA was performed
with the SuperScript III Reverse Transcriptase kit (Life technologies) using the manufacturer’s
protocol and stored at -20°C.
The RT-qPCR was performed using Blue Precision MasterMix with ROX premixed with
SYBR Green (Primer Design Ltd) following the manufacturer’s protocol for geNorm selection
of reference genes. Amplification and detection of specific products were carried out with the
7500 Fast Real Time System (TaqMan1; Applied Biosystems) with the following cycle profile:
95°C for 10 mins and then 40 cycles at 95°C for 15 sec and 60°C for 30 sec. On completion of
the assay, a dissociation stage was carried out for melting curve analysis.
Analysis of experimental data
All samples used to assay each gene, including standard curves, were carried out on a single
plate, using a single threshold setting in the ABI 7500 software, eliminating the need for inter-
run corrections due to different effective thresholds.
For standard curves, ten-fold dilution series were made so that the range of observed quantifica-
tion cycle (Ct) values encompassed those obtained for all experimental samples. Linear regression
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of Ct as a function of logarithm to base 2 (log2) of the relative template concentration was carried
out with the lm function in R, providing the slope and its standard error. Log2 were used through-
out, so that a slope of -1 is expected for perfect two-fold amplification per cycle, easing intuitive
assessment. Regressions were carried out using the R function plot.stds, included in S1 Text.
Before further processing, all Ct of experimental samples were adjusted by dividing by the
slope of the standard regression curve for the appropriate gene. The resulting value is the log2
of the amount of transcript present at the start of the assay, relative to the threshold amount.
This compensates for efficiency differences between transcripts, so that equal differences in
this measure represent the same ratio between samples, whichever transcript is considered.
The threshold amount, whose log2, is the intercept of the regression, is arbitrary and subject to
large errors because it is far outside the range of the standard curve points. Thus the absolute
measure has no useful meaning, and only differences, giving the ratios between two samples,
are useful. For the majority of assays, the 95% confidence interval for the slopes spanned 1.0, so
that the correction was not strictly required, and simple ΔΔCqmethods would also have been
appropriate. However, the adjustment was included for all assays for the sake of consistency
with those assays which had slightly lower efficiencies.
All statistical calculations were carried out using data on the logarithmic scale, converting
log differences to ratios only after all calculations were complete. There are several reasons for
avoiding the use of intermediate values produced by exponentiation: it greatly simplifies all cal-
culations, especially those dealing with experimental error and it maintains the data in the
native logarithmic domain generated by the PCR assay system. Both experimental error and
biological variation of the measurements are generally normally distributed on the logarithmic
scale, so that assumptions underlying some parametric statistical methods are valid only by
keeping data on this scale. For data with high variability, the lower bounds of confidence inter-
vals calculated on linear scale data can be below zero, which is nonsensical.
Evaluation of candidate reference genes. Selection of stable reference genes in either of
the two experimental contexts was carried out using the implementations of geNorm and
Normfinder algorithms in the R package NormqPCR [9]. This adds a stepwise selection proce-
dure to the original Normfinder algorithm. Wrapper functions used for these analyses are pro-
vided and described in S1 Text. geNorm analysis, of both SYBR Green and TaqMan qPCR data
was also performed using the qbase+ software version 2.6 (Biogazelle).
Statistical modelling. The gls function of the nlme package in R was used for comparing
levels of transcripts in experimental groups, because it allows the selection and evaluation of a
variety of different error models. The results indicated the use of different variances only per
gene, constant across factors, in both the tissue dataset and the infected fibroblast dataset. The
selected models were analysed with the glht function of themultcomp package. The over-con-
servative Bonferroni correction of p values for multiple testing was used throughout. Details
are provided in the R functions in S1 Text, and a flowchart describing the workflow for analysis
is provided in S1 Fig. Considerations for underlying principles and treatment of error/uncer-
tainty are summarised in S3 Text.
All Ct data for standard curves and for experimental samples are provided in S1 File, in a
form suitable for input to R.
Results
Selection and testing of stable reference gene primer and probe sets
After tests with prospective primer sets, some of these were discarded as they were clearly
highly variable (data not shown), leaving ten candidate reference transcripts. Details of these
are provided in Table 1.
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Primers and probe sets for these genes were selected as described in the methodology.
Results of tests with DNA templates showed that it was necessary to have the entirety of
each primer within a different exon, so that the amplicon spanned an intron-exon boundary,
excluding the amplification of DNA. Intron-spanning primers were not sufficient. Using these
criteria, we also ensured that each probe sequence spanned the intervening intron, and we
chose the larger of alternative introns when possible. The selected primers and corresponding
probes are listed in Table 2. The layout of the selected oligonucleotides with respect to the
spanned introns, and the intron lengths, are shown in Fig 1.
The selected primer and probe sets were tested in the qPCR assays to ensure that they did
not produce a signal with genomic DNA template (Fig 2). For all ten assays 10 ng of RNA gave
a Ct value between 20 and 27, while 20 ng of DNA gave no signal even after the maximum 40
cycles. Thus even 100% DNA contamination of 20 ng RNA samples, such as those analysed in
the experiments described here, would yield no signal from DNA.
Amplification efficiency and linear dynamic range of each assay was evaluated by plotting
standard curves of a dilution series of HD11 cell line total RNA, with the results shown in Fig
3. All regressions were linear over the range of the dilutions used, which included the transcript
concentrations found in experimental samples. Slopes were very close to the -1.0 expected for
perfect two-fold amplification per cycle. The accuracy of linearity over the full dilution range
was dependent on the inclusion of carrier RNA in the dilution medium. Without carrier, the
amplifications appeared to become less efficient at higher dilutions, possibly because of loss of
RNA by adsorption on the walls of containing vessels. This effect was especially evident with
ribosomal RNA assays, for which 100-fold higher dilutions were required because of the high
abundance of the target. Essentially similar linearity and efficiencies were obtained using puri-
fied amplicon as template.
Dissociation curves of the amplified products of all SYBR Green assays were carried out to
ensure their specificity. A typical result for each gene is shown in Fig 4. All exhibited a single
sharp peak, indicating that only one product was amplified and that no primer dimers were
formed.
Identifying stably expressed reference genes
After verification of the quality of the assays, they were evaluated for their suitability as a set of
potential reference transcript assays in two experimental scenarios, a panel of tissue RNA sam-
ples and samples of RNA from fibroblasts, with and without preincubation with interferon α
before influenza virus or mock infection.
Table 1. Candidate reference genes.
Gene Full name ENA/Genbank Refseq ENSEMBL
ACTB Beta actin L08165 NM_205518 ENSGALT00000015673
B2M Beta-2-microglobulin M84767 NM_001001750 ENSGALT00000040255
HMBS Hydroxymethylbilane synthase BX932073 XM_417846 ENSGALT00000000380
HPRT1 Hypoxanthine phosphoribosyl transferase 1 AJ132697 NM_204848 ENSGALT00000009843
PGK1 Phosphoglycerate kinase 1 L37101 NM_204985 ENSGALT00000012893
PLA2 Phospholipase A2 group IV A U10329 NM_205423 ENSGALT00000008121
PPIA Peptidylprolyl isomerase A (Cyclophilin A) GQ849480 NM_001166326 ENSGALT00000044106
RPL13 Ribosomal protein L13 D26318 NM_204999 ENSGALT00000009974
RPLP0 Ribosomal phosphoprotein P0 L28704 NM_204987 ENSGALT00000011731
TBP TATA box binding protein D83127 NM_205103 ENSGALT00000037720
doi:10.1371/journal.pone.0160173.t001
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The stability of the reference gene transcripts was analysed using the geNorm stepwise algo-
rithm. For each of the two sample sets, raw Ct values from TaqMan assays for each gene on
each sample were analysed using the stepwise geNorm algorithm. Fig 5 shows the results of
successive elimination of the least stable transcripts in each experiment. For the tissue samples,
the graphs (A and C) were similar to those described by Vandesompele [5]. Four genes
(HMBS, TBP, RPL13 and RPLP0) were included before the next addition took the bar below
the threshold criterion of 0.15 on the lower graph. There was an exceptional increase upon
addition of the last gene, PGK1, indicating substantial instability because of differential expres-
sion of this transcript between the samples or tissues. This is consistent with the sharp drop in
the stability parameter upon elimination of this gene evident in Fig 5. As subsequent analysis
confirmed substantial differences in PGK1 transcript levels, especially in muscle, both geNorm
and NormFinder were re-applied omitting this gene before normalisation for downstream
analysis. The 28s rRNA assay was also omitted, as its use would require additional dilutions,
and thus additional opportunity for error. Neither omission changed the order of the first five
genes selected by geNorm.
Table 2. Primer and probe sequences for qRT-PCR
Gene Type Sequence Exon Amplicon*
ACTB Forward 5’-CAGGTCATCACCATTGGCAAT-3’ 3 149/455
Reverse 5’-GCATACAGATCCTTACGGATATCCA-3’ 4
Probe 5’-(FAM)CACAGGACTCCATACCCAAGAAAGATGGC(TAMRA)-3’ 3/4
B2M Forward 5’-AAGGAGCCGCAGGTCTAC-3’ 2 151/1138
Reverse 5’-CTTGCTCTTTGCCGTCATAC-3’ 4
Probe 5’(FAM)CCGGGATGAGCACGGTCTGAAGAATT(TAMRA)-3’ 3/4
HMBS Forward 5’-GGTTGAGATGCTCCGTGAGTTT-3’ 3 153/798
Reverse 5’-GGCTCTTCTCCCCAATCTTAGAA-3’ 4
Probe 5’-(FAM)CCTGACCTCTGCTTTGAGATTGTTGCCA(TAMRA)-3’ 3/4
HPRT1 Forward 5’-TGGTCAAAAGAACTCCTCGAAGT-3’ 6 96/972
Reverse 5’-TGTAATCGAGGGCGTATCCAA-3’ 7
Probe 5’-(FAM)TCCAACAAAGTCTGGCCGATATCCCA(TAMRA)-3’ 6/7
PGK1 Forward 5’-GTTTATGTCAATGATGCTTTTGGAA-3’ 4 82/431
Reverse 5’-GCCTTTGCAAAATAATCCAGTTCT-3’ 5
Probe 5’-(FAM)CATCGTGCTCACAGCTCCATGGTAGGT(TAMRA)-3’ 4/5
PLA2 Forward 5’-GCACAAGACATTTGGCAGTTGT-3’ 2 138/5846
Reverse 5’-TGTGACATTTGTGGCTTTCCTTA-3’ 3
Probe 5’-(FAM)CAACACATTGTGGTGGAACACCAGTACTCA(TAMRA)-3’ 2/3
PPIA Forward 5’-CCCGTCGTGTTCTTCGACAT-3’ 1 140/>450
Reverse 5’-CCCTTGTAGCCAAATCCCTTCT-3’ 2
Probe 5’-(FAM)CACCTTCGAGCTCTTCGCTGACAAGG(TAMRA)-3’ 1/2
RPL13 Forward 5’-TCGTGCTGGCAGAGGATTC-3’ 3 71/908
Reverse 5’-TCGTCCGAGCAAACCTTTTG-3’ 4
Probe 5’-(FAM)TAATGCCCGCCAGTTTAAGCTCTTCTAGGC(TAMRA)-3’ 3/4
RPLP0 Forward 5’-TTGGGCATCACCACAAAGATT-3’ 4 82/431
Reverse 5’-CCCACTTTGTCTCCGGTCTTAA-3’ 5
Probe 5’-(FAM)CATCACTCAGAATTTCAATGGTCCCTCGGG(TAMRA)-3’ 4/5
TBP Forward 5’-CTTCGTGCCCGAAATGCT-3’ 4 82/1689
Reverse 5’-GCGCAGTAGTACGTGGTTCTCTT-3’ 5
Probe 5’-(FAM)CTCATAATAACAGCAGCAAAACGCTTGGGA(TAMRA)-3’ 4/5
* Lengths of predicted amplicons from mRNA/DNA in base pairs
doi:10.1371/journal.pone.0160173.t002
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Fig 1. Layout of primers and probes for reference genes. Exons are indicated by black bars and introns by
connecting lines. Dashed lines are sequences missing from the assembled genome sequence. Reading frames
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With the fibroblast data, the geNorm cut-off criterion is already reached with just two genes
in the pool, HPRT1 and RPLP0. The stability values were all better than the best obtained for
the tissue panel data, possibly reflecting the homogeneous nature of the cell line compared
with the complexity of the tissue samples.
While removal of the clearly differentially expressed PGK1 from the input for geNorm for
the tissue data made no difference to the ranking of the remaining genes, this was not the case
with NormFinder. With PGK1, the NormFinder ranking was RPL13, RPLP0, TBP and HMBS,
the same four top ranked genes as with geNorm, but in different order. When PGK1 was
excluded, NormFinder selected TBP, RPL13, HMBS and ACTB. Similarly with the infected
fibroblast data, removal of B2M, the least stably expressed candidate reference gene in this
experiment, made no difference to the geNorm ranking, but changed the ranking by NormFin-
der from HPRT1, HMBS, RPLP0, TBP, with B2M, to HPRT1, RPLP0, ACTB, PGK1, without
B2M. The latter was the same as the geNorm rankings.
Normalisation of fibroblast interferon and infection data. The four top ranked genes,
from either selection method after exclusion of the differentially expressed B2M, were used to
normalise the measurements of the remaining six candidate transcripts, as well as IL-8 and
TGFB transcripts, in the fibroblast infection dataset. The other candidate genes represent
examples of genes with little difference in expression, providing a sensitive test of the effects of
the normalisation on statistical analysis. Statistical modelling with gene-specific variance fol-
lowed by conservative testing for significant differences in transcript levels (Bonferroni correc-
tion) was used to compare the results of normalisation with the selected genes or with 28s
ribosomal rRNA. The results are shown in Fig 6, where asterisks indicate the strength of evi-
dence for differential expression between experimental groups.
As expected from the diagnostic plots for the stepwise process in geNorm, in this experi-
ment there is little difference between using the most stable gene, HPRT1, singly or in combi-
nation with further genes. The comparison is, however, useful in giving indications that a few
are all shown left-to-right. Primers are green arrows. Probes are blue or red for forward and reverse strand
sequences respectively.
doi:10.1371/journal.pone.0160173.g001
Fig 2. Primer-probe sets do not produce signals with DNA template. The primer-probe sets for the indicated transcripts were used in
combined reverse-transcriptase-qPCR assays with HD11 cell line total RNA template (blue, 100, 10 and 1 ng), splenic DNA template
(red, 20ng) or no template (green). The plots show background-subtracted fluorescence as a function of cycle (1–40) on a logarithmic
scale. Missing points correspond to fluorescence levels lower than or equal to zero after automatic baseline subtraction. The heavy black
line is the detection threshold used for all analyses.
doi:10.1371/journal.pone.0160173.g002
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Fig 3. Linear regressions for efficiency of qPCR assays. Serial ten-fold dilutions of HD11 cell line RNA were analysed in
duplicate for each candidate reference transcript. The Ct (y axis) were plotted against the log2 of the relative RNA
concentrations (x axis). Names of transcripts are at the top of each graph. The inset shows the results of linear regression. SE
is the standard error of the slope; CI indicates the 95% confidence interval; fold/cycle is the efficiency and RSq is the R
squared value.
doi:10.1371/journal.pone.0160173.g003
Chicken qPCR Reference Assays
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Fig 4. Melting curves of reference gene PCR products following SYBRGreen assays. Blue curves show the
rate of change of fluorescence as a function of temperature. Red bars indicate 65 and 90°C. The peak temperature
for each curve is given next to the transcript name and is indicated with a vertical dashed line.
doi:10.1371/journal.pone.0160173.g004
Chicken qPCR Reference Assays
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of the differences may be less robust in the face of different normalisations than are others.
When the results with reference gene normalisations are compared with those using rRNA as
reference, the differences are striking. Although the differential expression of B2M remains
clear, PLA2 appears to have no differential expression when compared with the selected refer-
ence genes, but clearly significant differences when compared with rRNA. Conversely, IL-8
appears differentially expressed when analysed using selected reference genes, but not when
using rRNA. There are fewer differences with the other genes. So in this experimental context,
comparison with the reference gene set and with rRNA will yield different conclusions about
differential expression. It should be emphasised that the differences in expression here are
Fig 5. geNorm stepwise analysis of TaqMan analyses. Left (A, C), tissue panel; right (B,D), fibroblast/flu
experiment. The upper graphs (A,B) show the change in stability measure [5] after eliminating the least stable
gene, which is indicated on the x axis, at each step. The lower graphs (C,D) show the standard deviations of the
differences in sample normalisation following successive additions of reference genes to the pool. Lowering of the
bar is a measure of the improvement obtained by adding the indicated gene to the pool. The dashed line shows the
0.15 cut off level suggested as a criterion by Vandersompele [5] to stop adding genes.
doi:10.1371/journal.pone.0160173.g005
Chicken qPCR Reference Assays
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small. For B2M, the maximum inter-group difference is estimated at about 3.5-fold or 3-fold
with reference gene or rRNA normalisations, and the detection is unaffected by the choice.
Estimates for PLA2 and IL-8, on the other hand, differ by up to about two-fold in the case
where differential expression is detected and 1.2 to 1.3 fold where it is not.
All the estimated relative expression levels, and their confidence intervals, are shown in Fig
6B. It is clear that, compared with the reference normalisation, the relative level of rRNA in the
infected cells is increased, so that using rRNA to normalise results in lower apparent levels of
transcripts in these groups. That suppresses the increased expression of IL-8 evident with refer-
ence gene normalisation. It also causes the detection of significant decrease in the case of
PLA2, which is not modulated at all with the reference gene normalised data. The effects of
normalisation on individual samples, reduction of dispersion and removal of intra-group dif-
ferences common to different genes, are illustrated in S2 Fig.
Normalisation of tissue panel data. All the candidate reference transcripts and rRNA
were measured in total RNA samples of thirteen tissues from six birds. The means and distri-
butions of measurements, before and after different normalisations, are compared in Fig 7.
Data from muscle samples is excluded here because the large differential expression of PGK1,
responsible for its rejection as a reference candidate, would not fit on the scale used. All the
normalisations substantially reduced the dispersion, represented by the error bars, of measure-
ments from replicates of the same tissue, for all the measured genes, not just those used for nor-
malisation. The means were also reduced in many cases, particularly the skin samples which
were known, from A260 measurements, to have less RNA than other samples.
Fig 6. Effect of reference genes on detection of differential expression in an influenza-infected fibroblast experiment. (A) The title above each
column indicates the set of genes used as reference genes for normalisation. Each row shows the results of statistical analysis for the gene indicated to
the left. Experimental groups labelled 'u' or 'i', for uninfected and infected, and 'a' or 'c' for preincubation with or without IFNα. Asterisks indicate p values
for rejection of the null hypothesis that a gene is not differentially expressed in the groups indicated by row and column labels; *** = p<0.001, ** =
p<0.01, * = p<0.05. (B) Estimated transcript levels relative to the uninfected control without IFNα. Dotted lines are at unit log2 intervals, representing
two-fold changes. Bars represent means of biological replicates, with 95% confidence intervals indicated by error bars. Annotations show the transcripts
used for normalisation (left margin), the transcripts assayed (above) and the treatment, encoded as above.
doi:10.1371/journal.pone.0160173.g006
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Fig 7. Transcript levels of candidate reference genes in tissues. Bars are means from samples from six birds, relative to the
mean across tissues, plotted on a log2 scale. Dotted lines are at unit intervals, equivalent to 2-fold differences. Error bars are ± one
standard deviation in each group, without pooling of variances. The left column shows un-normalised data. The remaining columns
show the same data after normalisation with the reference genes indicated beneath, or with ribosomal RNA on the right. Measured
genes are indicated to the left of each plot, marked with an asterisk where they were among those used for normalisation. Tissues
are identified at the top. Colours of bars distinguish tissues with different categories of immunological function.
doi:10.1371/journal.pone.0160173.g007
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Reduction of dispersion of the data for the genes used for normalisation is an inevitable con-
sequence of their use. However, the similar flattening out of the means for these genes shows
that there is very limited inter-tissue variation, and thus that the selection of stable genes was
successful. The PPIA data is similarly flattened although it was not used in the normalisation.
Other genes show reduced but significant differences between tissues, including ACTB which
was selected by NormFinder in place of RPLP0 selected by geNorm. Careful inspection of the
ACTB profiles reveal that the inter-tissue differences are mostly in the opposite sense to those
of the three genes selected by both algorithms, Thus the inclusion of ACTB provides an exam-
ple of NormFinder's ability to select compensating deviations from stable expression.
Despite this difference, the results of normalisation are very similar for both reference gene
selection algorithms using this dataset, as they were for the fibroblast data. Apart from the
genes used in normalisation, normalisation with ribosomal RNA appeared to offer similar per-
formance in reducing dispersion of levels among biological replicates. However, in spite of an
overall similarity, for instance in removing the skin sample bias, there were some clear differ-
ences. Most obvious are the differences in the means for most genes in liver. These lead to dif-
ferences in the detection of significant differential expression (S3 Fig) for genes like the unused
candidate reference genes, where differences are small.
Discussion
To be comparable across different experimental groups, measurements of transcript levels have to
be expressed relative to a common base quantity. Although it is rarely explicitly identified, perhaps
the most common implied basis is the level relative to the total number of mRNA transcripts.
It is in that context that the use of mRNA reference transcripts, whose low variability allow
them to represent the total mRNA population, is appropriate. It is by now well established that
one reference transcript is rarely sufficient, so that combinations must be used to attain low
variation. Furthermore, it has been clearly demonstrated that there is no universal combination
suitable for all investigations, and thus that a suitable combination has to be selected for every
new experimental context. This means that a versatile panel of potentially appropriate candi-
date assays is required. We generated a suitable panel of ten assays with high amplification effi-
ciencies and specificity, free from interference from contaminating genomic DNA, for use in
chickens. In the course of that development we found that it was essential to verify the lack of
genomic DNA amplification experimentally rather than relying on primer design rules. We
also found that standard curves showing the best linearity over a large dynamic range required
the presence of carrier RNA in the diluent. With these precautions we were able to show that
the panel allowed the selection of suitable reference genes using established methods, and that
their use yielded improvements in minimising variation, and greater sensitivity in detection of
differential expression, in two experimental contexts. As expected, different combinations of
transcripts were appropriate for each context because different members of the panel were
excluded because of differential expression in the two systems.
It is important to emphasise that the reference genes selection results reported here cannot
be extrapolated without explicit testing in every case. For example, it should not be assumed
that reference genes suitable for this tissue panel will be suitable for a different selection of tis-
sues, or for birds of different genetics or age. There is no alternative to testing in each new
experimental context. Similarly, the reference genes that work best in the fibroblast infection
experiment we analysed should not be assumed to be appropriate for other time points, other
viruses, other interferon treatments, or even for fibroblasts from other lines of chickens.
The 28s ribosomal RNA assay we used here has been used for normalisation in a wide vari-
ety of investigations in chickens. For transcripts with very small differences in levels,
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exemplified here by the unselected candidate genes in each system, we found that there could be
differences in the detection of differential expression using this instead of the selected reference
mRNAs for normalisation. However, this does not imply that all analyses that used the 28s rRNA
assay are suspect. First, the greatest differences we saw were less than four-fold, and most much
smaller. So only those conclusions based on very small differences are open to reinterpretation.
Second, in very many cases, the biological interpretation depends not on the ratios of one tran-
script in different groups, but rather on the ratio of different transcripts. An example of this in
avian science is to be found in the developing bursa, where the requirements for B cell survival
appear to change, dependent on the ratio of BAFFR and TACI mRNAs [10]. In those cases, the
method used for normalisation does not affect the result, as the normalisation factor cancels out
in the ratio of two other transcripts. Although our data are enough to prefer the use of mRNA
reference genes in future, they do not imply that existing work using 28s RNA should be rejected.
In the case of the influenza infected fibroblasts, an increase of IL-8 mRNA in infected cells
was evident using normalisation with the mRNA reference transcripts, but not using 28s rRNA.
At first sight this appears to be a failure of the 28s normalisation, the rRNA having increased rela-
tive to the reference transcripts. However, it is known that infection with influenza virus causes a
general suppression of host cell mRNA [11]. So the level of IL-8 mRNA per cell may indeed be
unaltered, and if that is the quantity pertinent to biological interpretation, then it is the 28s rRNA
that may provide the more appropriated normalisation. This case illustrates the danger of
unthinking adherence to prescriptions for data analysis prescribed in manifestos such as the
MIQE [12–15]. Generalised guidelines are of great value in drawing attention to the important
considerations, but are not a panacea to be followed blindly. They cannot absolve author or ref-
eree from the responsibility for critical evaluation of analyses in each specific case.
There are many other experimental situations where employment of the normalisation strate-
gies described here are inappropriate. For example, when assays are carried out in cell cultures in
which cell populations may be rapidly changing by cell death and/or proliferation of bystander
cells in response to experimental variables, internal reference normalisation may completely
obscure effects confined to a stable subset of cells. In such cases, the appropriate basis may be the
amount of transcript per culture well. If RNA recovery is significantly variable, spiking with cells
carrying a unique reference transcript, immediately prior to RNA extraction, can provide a more
appropriate normalisation. In infected tissues, whose cellular composition and size may vary dra-
matically with experimental conditions, the relevant basis may be numbers of mRNAmolecules
per gram of tissue, or even number in the whole tissue. Neither of these is likely to be well repre-
sented by any internal reference transcripts, so that spiked references may again be required if
the ultimate scientific interpretation depends on the control of variation in RNA recovery.
The original NormFinder implementation [6] provided for selection of only up to two refer-
ence genes, although the publication described the mathematical basis for evaluating combina-
tions of more than two. The NormqPCR package provided a stepwise procedure implementing
those calculations. However, there are two ways the NormqPCR stepwise process might be
improved. First, because of the possibility of compensation of inter-group differences between
pairs of genes, the best combination of a number of genes does not necessarily include those in
the smaller combinations, but the NormqPCR procedure always includes them. Second, by not
eliminating the least stable gene an opportunity is missed to reduce bias in the overall average
expression, and thus in the selection, by elimination of candidates with the greatest individual
inter-group differences. We implemented a new version of the stepwise procedure that tested
all combinations of increasing size, not just those including the previously selected smaller
combination. That was then enclosed within another stepwise loop that successively eliminated
the least stable gene from the initial set of candidates. Parameters were also added to set a mini-
mum individual stability for inclusion in the combinations, either by stability value or by rank,
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as was provided for the pairwise combinations in the original NormFinder procedure. The output
provides stability measures for all examined combinations, as well as the output that would be pro-
duced by the NormqPCR procedure, for each iteration of the outer loop. This procedure is pro-
vided in S2 Text, and example results in S4 Fig. In general the improvement in stability obtained
with the new procedure, compared with the existing NormqPCR procedure, was small enough
that effects on the statistical analysis of experimental data were not useful. Therefore the results
presented here are those using the combinations selected by the simpler NormqPCR procedure.
Robustness of reference gene selection in the tissue data was tested by removing one tissue
at a time from the panel. The geNorm selection was relatively robust, while ranking by Norm-
Finder was much more sensitive to these changes in the input data (S6 Fig). It is likely that the
advantage of NormFinder in being able to select reference genes with compensating inter-
group differences for a given dataset may come at the cost of decreased robustness with differ-
ent input data. This may be a factor in choosing between these selection algorithms depending
on the intended application.
Threshold based standard curve methods have been criticised because of their assumption
of constant PCR efficiency in the cycles preceding achievement of the threshold signal, and
potential variability of efficiency between samples [16]. In response, several methods have been
developed based instead on the estimation of efficiencies in individual amplification curves.
These are compromised by their dependence on fitting data obtained after achievement of the
detectable signal, inevitably approaching or including the non-exponential phase of amplifica-
tion, so that they cannot assess the progress of the amplification in the preceding part of the
reaction except by extrapolation. Lack of linearity of standard curves based on dilution series
[17] and lower efficiency at higher dilution have been advanced as reasons to support the use
of these alternatives. In our experiments we found that inclusion of carrier RNA in dilution
medium dramatically improved the linearity of standard curves and improved some otherwise
apparently low efficiencies, especially at the high dilutions used for the rRNA assay. Thus
major questionable characteristics of standard curves, used to justify rejection of the assump-
tion of constant amplification efficiency, may be attributable to adsorbtion of nucleic acids on
the walls of dilution vessels. This would also be expected to result in higher variance at higher
dilutions, an effect documented by Boggy &Woolf [17]. We are not aware of others having
emphasized the improvements obtainable with carrier. Whether or not our hypothetical expla-
nation for the improvement is correct, the standard curves we obtained demonstrated excellent
linearity over ranges of starting template concentrations including all experimental values, jus-
tifying use of the constant efficiency assumption and thus of the applicability of the threshold-
based method of quantification.
A general schematic for the design and application of reference gene assay is given in S5 Fig.
In summary, we have described a rigorous process by which to design qPCR primer and probe
sets for mRNA transcripts; shown the importance of experimentally determining their inability
to amplify genomic DNA; provided a panel of reference gene assays from which to select by
experiment those with best utility for particular applications; described their use in the normal-
isation of experimental data and lastly have discussed when approaches other than this may
better fit the biology of particular experiments.
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